Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
University of Utah
ClinicalTrials.gov Identifier:
NCT01614184
First received: March 6, 2012
Last updated: July 8, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)